Evidence map›Paper›PMID 21697343›Full record

ArticleThe Journal of general virology2011

Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships.

Małgorzata Rychłowska, Ania M Owsianka, Steven K H Foung, Jean Dubuisson, Krystyna Bieńkowska-Szewczyk, Arvind H Patel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of general virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Małgorzata RychłowskaMRC-University of Glasgow Centre for Virus Research, 8 Church Street, Glasgow G11 5JR, UK.
Ania M OwsiankaMRC-University of Glasgow Centre for Virus Research, 8 Church Street, Glasgow G11 5JR, UK.
Steven K H FoungDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94304, USA.
Jean DubuissonInserm U1019, F-59019 Lille, France.
Krystyna Bieńkowska-SzewczykDepartment of Molecular Virology, University of Gdańsk, Kładki 24, 80-822 Gdańsk, Poland.
Arvind H PatelMRC-University of Glasgow Centre for Virus Research, 8 Church Street, Glasgow G11 5JR, UK.
MRC University of Glasgow Centre for Virus Research · GBInstitut Pasteur de Lille · FRStanford University · USUniversity of Gdańsk · PL

Funding

Neutralizing Antibodies to Hepatitis CR01HL079381 · NHLBI · STANFORD UNIVERSITY · PI FOUNG, STEVEN · 2004 to 2008
$2.8M
B Cell Immunity to Hepatitis C VirusR56AI081903 · NIAID · STANFORD UNIVERSITY · PI FOUNG, STEVEN · 2009 to 2009
$406k
Medical Research Council MC_U130184144NHLBI NIH HHS HL079381NHLBI NIH HHS R01 HL079381NIAID NIH HHS AI081903NIAID NIH HHS R56 AI081903
6 · The paper itself

Abstract

Despite extensive research, many details about the structure and functions of hepatitis C virus (HCV) glycoproteins E1 and E2 are not fully understood, and their crystal structure remains to be determined. We applied linker-scanning mutagenesis to generate a panel of 34 mutants, each containing an insertion of 5 aa at a random position within the E1E2 sequence. The mutated glycoproteins were analysed by using a range of assays to identify regions critical for maintaining protein conformation, E1E2 complex assembly, CD81 receptor binding, membrane fusion and infectivity. The results, while supporting previously published data, provide several interesting new findings. Firstly, insertion at amino acid 587 or 596 reduced E1E2 heterodimerization without affecting reactivity with some conformation-sensitive mAbs or with CD81, thus implicating these residues in glycoprotein assembly. Secondly, insertions within a conserved region of E2, between amino acid residues 611 and 631, severely disrupted protein conformation and abrogated binding of all conformation-sensitive antibodies, suggesting that the structural integrity of this region is critical for the correct folding of E2. Thirdly, an insertion at Leu-682 specifically affected membrane fusion, providing direct evidence that the membrane-proximal 'stem' of E2 is involved in the fusion mechanism. Overall, our results show that the HCV glycoproteins generally do not tolerate insertions and that there are a very limited number of sites that can be changed without dramatic loss of function. Nevertheless, we identified two E2 insertion mutants, at amino acid residues 408 and 577, that were infectious in the murine leukemia virus-based HCV pseudoparticle system.

Indexed as

Antigens, CDCell LineHumansMembrane FusionModels, MolecularMutagenesis, InsertionalProtein BindingProtein ConformationProtein MultimerizationReceptors, VirusTetraspanin 28Viral Envelope ProteinsAntigens, CDCD81 protein, humanE1 protein, Hepatitis C virusglycoprotein E2, Hepatitis C virusReceptors, VirusTetraspanin 28Viral Envelope Proteins

Identifiers

PMID21697343
PMCPMC3347801
OpenAlexW2137706013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.